Insights+

Insights+: The US FDA New Drug Approvals in August 2023

Insights+: The US FDA New Drug Approvals in August 2023

Shots: The US FDA approved 10 NDAs and 3 BLA in August 2023, leading to treatments...

New Drug Designations - August 2023

New Drug Designations - August 2023

Shots:  PharmaShots' designation report provides a concise overview...

Disease of the Month- Mesothelioma

Disease of the Month- Mesothelioma

Shots:  To keep our readers acquainted with several disease conditions, ongoing trials,...

Insights+ Key Biosimilars Events of August 2023

Insights+ Key Biosimilars Events of August 2023

Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and...

Know Your Investor: RA Capital Management LLC

Know Your Investor: RA Capital Management LLC

Shots: PharmaShots’ second dose of the Know Your Investor series focuses on...

Insights+: EMA Marketing Authorization of New Drugs in July 2023

Insights+: EMA Marketing Authorization of New Drugs in July 2023

Shots: The EMA approved 9 New Chemical Entity (NCE) and 5 Biologic Drugs in July 2...

Image